Phathom Pharmaceuticals, Inc. filed a current report on November 18, 2026, disclosing that Robert Breedlove, Vice President, Finance and principal accounting officer, notified the company of his resignation effective December 4, 2026.

Key Highlights

  • Resignation notice: Robert Breedlove informed Phathom Pharmaceuticals of his intent to resign on November 12, 2026.
  • Effective date: The resignation is effective December 4, 2026.
  • Role: Breedlove holds the title of Vice President, Finance and serves as the company's principal accounting officer.
  • Continued service: He will continue to serve in his current role through the effective date of December 4, 2026.
  • No disagreement: According to the filing, Breedlove's resignation "was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices."

Phathom Pharmaceuticals Discloses Principal Accounting Officer Departure

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT), headquartered in Florham Park, New Jersey, reported under Item 5.02 of the current report that Robert Breedlove notified the company on November 12, 2026 of his decision to resign as Vice President, Finance and principal accounting officer. The filing states his last day in the role will be December 4, 2026.

According to the filing, Breedlove will remain in his position and continue carrying out his duties as principal accounting officer through the effective date of his departure. The company disclosed that the resignation "was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices," the standard language used under Item 5.02 disclosures of this type.

The report was signed on November 18, 2026, by Anne Marie Cook, Chief Legal Officer of Phathom Pharmaceuticals, on behalf of the registrant. The filing did not name a successor to Breedlove's role or provide details regarding any transition plans.

What Was Disclosed

Phathom Pharmaceuticals filed an 8-K on November 18, 2026, disclosing the resignation of Robert Breedlove, Vice President, Finance and principal accounting officer, effective December 4, 2026, with no disagreement cited as the cause.